The Role Of AI In Drug Discovery: Accelerating Pharmacological Innovations

Ms. Nandinee P. Lavhe; Ms. Sayali D. Zinge; Ms. Shraddha G. Shirsat; Ms. Bhakti D. Phand

The Role Of AI In Drug Discovery: Accelerating Pharmacological Innovations

Authors: Ms. Nandinee P. Lavhe, Ms. Sayali D. Zinge, Ms. Shraddha G. Shirsat, Ms. Bhakti D. Phand

Unique Paper ID: 174571
Volume: 11
Issue: 11
PageNo: 16-20

Keywords: AI In Drug Discovery Pharmacological Innovations.

Abstract:
The integration of Artificial Intelligence (AI) in drug discovery is revolutionizing the pharmaceutical industry by accelerating the identification, development, and optimization of novel therapeutics. Traditional drug discovery methods are time-consuming, costly, and often suffer from high failure rates. AI-driven approaches, including machine learning (ML), deep learning (DL), and natural language processing (NLP), enable rapid analysis of complex biological datasets, prediction of molecular interactions, and identification of potential drug candidates with enhanced precision.AI-powered computational models streamline hit identification, lead optimization, and biomarker discovery by leveraging vast biochemical and genomic data repositories. Advanced algorithms facilitate virtual screening, structure-based drug design, and de novo drug synthesis, significantly reducing experimental costs and development timelines. Additionally, AI-driven pharmacovigilance systems enhance drug safety monitoring by detecting adverse drug reactions (ADRs) through real-world evidence and electronic health records (EHRs).Despite its transformative potential, AI-driven drug discovery faces challenges such as data quality, model interpretability, regulatory compliance, and ethical considerations. Addressing these hurdles requires interdisciplinary collaboration between pharmaceutical scientists, bioinformaticians, and regulatory bodies. The future of AI in drug discovery lies in the integration of quantum computing, federated learning, and multi-omics data to achieve precision medicine breakthroughs.This paper explores AI's role in drug discovery, highlighting its impact on target identification, drug repurposing, and clinical trial optimization. By harnessing AI's predictive capabilities, the pharmaceutical industry can accelerate pharmacological innovations, ultimately improving patient outcomes and reducing healthcare burdens.

Download article

email to a friend

Cite This Article

ISSN: 2349-6002
Volume: 11
Issue: 11
PageNo: 16-20

The Role Of AI In Drug Discovery: Accelerating Pharmacological Innovations

Available:https://ijirt.org/Article?manuscript=174571

16 May, 2025

Hydrogels And Their Medical Applications

09 May, 2025

ADVERSE DRUG REPORTING OF THE BENZODIAZEPINE GROUP

01 May, 2025

Formulation And Evaluation Of Lipbalm

30 Apr, 2025

Avocado Gel: Herbal Solution For Skin Nourishment

24 Apr, 2025

Antidandruff Hair Herbal Gel For Dandruff-Free Hairs

05 Apr, 2025

Formulation And Evaluation Of A Herbal Face Pack Using Natural Ingredients

29 Mar, 2025

FORMULATION OF HERBAL LIP BALM FROM SELENICEREUS UNDATUS

21 Mar, 2025

Hydroxypropyl Methylcellulose (HPMC): As A Multitasking Excipient

10 Feb, 2025

A Review On AI (Artificial Intelligence) In Teaching And Learning Pharmaceutical Sciences And Medicine.

07 Nov, 2024

Current aspects of AI (artificial intelligence) in teaching and learning pharmaceutical sciences and medicine.

Impact Factor
8.01 (Year 2024)

UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry